Gill IS, Aron M, Gervais DA, Jewett MA (2010) Clinical practice. Small renal mass. N Engl J Med 362(7):624–34
Article CAS PubMed Google Scholar
Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98(18):1331–1334
Mirkheshti N, Farrukh N, Legesse T, Rowe SP, Gordetsky J, Hussain A (2022) Renal oncocytoma: a challenging diagnosis. Curr Opin Oncol 34(3):243–252
Article CAS PubMed Google Scholar
Amin MB, McKenney JK, Martignoni G, Campbell SC, Pal S, Tickoo SK (2022) Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis. Mod Pathol 35(10):1306–1316
Pierorazio PM, Hyams ES, Tsai S, Feng Z, Trock BJ, Mullins JK et al (2013) Multiphasic enhancement patterns of small renal masses (</=4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. Urology 81(6):1265–1271
Pedrosa I, Sun MR, Spencer M, Genega EM, Olumi AF, Dewolf WC et al (2008) MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics 28(4):985–1003
Roussel E, Capitanio U, Kutikov A, Oosterwijk E, Pedrosa I, Rowe SP et al (2022) Novel imaging methods for renal mass characterization: a collaborative review. Eur Urol 81(5):476–488
Article PubMed PubMed Central Google Scholar
Rowe SP, Gorin MA, Solnes LB, Ball MW, Choudhary A, Pierorazio PM et al (2017) Correlation of (99m)Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression. EJNMMI Res 7(1):80
Article PubMed PubMed Central Google Scholar
Rowe SP, Gorin MA, Gordetsky J, Ball MW, Pierorazio PM, Higuchi T et al (2015) Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma. Clin Nucl Med 40(4):309–313
Article PubMed PubMed Central Google Scholar
Gorin MA, Rowe SP, Baras AS, Solnes LB, Ball MW, Pierorazio PM et al (2016) Prospective evaluation of (99m)Tc-sestamibi SPECT/CT for the diagnosis of renal oncocytomas and hybrid oncocytic/chromophobe tumors. Eur Urol 69(3):413–416
Parihar AS, Mhlanga J, Ronstrom C, Schmidt LR, Figenshau RS, Dehdashti F et al (2023) Diagnostic accuracy of (99m)Tc-Sestamibi SPECT/CT for characterization of solid renal masses. J Nucl Med 64(1):90–95
Article CAS PubMed Google Scholar
Hes O, Trpkov K (2022) Do we need an updated classification of oncocytic renal tumors? : emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities. Mod Pathol 35(9):1140–1150
Siadat F, Mansoor M, Hes O, Trpkov K (2022) Kidney tumors: new and emerging kidney tumor entities. Surg Pathol Clin 15(4):713–728
Williamson SR, Gill AJ, Argani P, Chen YB, Egevad L, Kristiansen G et al (2020) Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: III: molecular pathology of kidney cancer. Am J Surg Pathol 44(7):47–65
Campbell SP, Tzortzakakis A, Javadi MS, Karlsson M, Solnes LB, Axelsson R et al (2018) (99m)Tc-sestamibi SPECT/CT for the characterization of renal masses: a pictorial guide. Br J Radiol 91(1084):20170526
Article PubMed PubMed Central Google Scholar
Salles DC, Asrani K, Woo J, Vidotto T, Liu HB, Vidal I et al (2022) GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms. J Pathol 257(2):158–171
Article CAS PubMed PubMed Central Google Scholar
Chen J, Zheng Q, Peiffer LB, Hicks JL, Haffner MC, Rosenberg AZ et al (2020) An in situ atlas of mitochondrial DNA in mammalian tissues reveals high content in stem and proliferative compartments. Am J Pathol 190(7):1565–1579
Article CAS PubMed PubMed Central Google Scholar
Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H et al (2014) The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 26(3):319–330
Comments (0)